Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs

Toxicologic Pathology

Volumn 26, Issue 2, 1998, Pages 185-200

  Prahalada, Srinivasa ^a   Stabinski, Lea G ^a   Chen, Howard Y ^a   Morrissey, Richard E ^a   De Burlet, Georges ^a   Holder, Dan ^a   Patrick, Darryl H ^a   Peter, Chennekatu P ^a   Van Zwieten, Matthew J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Anabolic effects; Body weight change; Catabolic effects; Erythroid depletion; Hepatic change; Insulin levels; Insulin resistance; Insulin like growth factor 1 (IGF 1) levels

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CHOLESTEROL; COLLAGEN; CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LIOTHYRONINE; PHOSPHORUS; POTASSIUM; SOMATOMEDIN C; THYROXINE; TRIACYLGLYCEROL;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DOG; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SKINFOLD THICKNESS; TOXICITY TESTING;

ANIMALIA; CANIS FAMILIARIS; SUIDAE;

EID: 0031970045     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339802600201     Document Type: Article

References (27)

1. Ascacio-Martinez JA and Barrera-Saldana HA (1994). A dog growth hormone cDNA codes for a mature protein identical to pig growth hormone. Gene 143: 277-280.
2. Bach MA, Chapman I, Farmer M, Schilling L, Vancauter E, Taylor AM, Bolognese J, Krupa D, Gormely G, and Thorner MO (1996). Paper presented at 10th International Congress of Endocrinology, Abstract OR15-2, p. 71.
3. Bowers CY (1996). Xenobiotic growth hormone secretagogues: Growth hormone releasing peptides. In: Growth Hormone Secretagogues, BB Bercu and RF Walker (eds). Springer-Verlag, New York, pp. 9-28.
4. Cahill M, Satiritz S, Patrick D, and Keuler J (1995). Insulin-like growth factor 1 (IGF-1) by extraction and radioimmunoassay in rodent and canine species. Clin. Chem. 41: S161 (abstract 566).
5. Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, and Striker GE (1988). Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-1. Am. J. Pathol. 131: 398-403.
6. Eigenmann JE (1984). Acromegaly in the dog. Vet. Clin. N. Am. Small Anim. Pract. 14: 827-836.
7. Eigenmann JE (1985). Growth hormone and insulin-like growth factor in the dog: Clinical and experimental investigations. Domest. Anim. Endocrinol. 2: 1-16.
8. Eigenmann JE and Venker-van Haagen AJ (1981). Progestagen-induced and spontaneous canine acromegaly due to reversible growth hormone overproduction: Clinical picture and pathogenesis. J. Am. Anim. Hosp. Assoc. 17: 813-822.
9. Feld S and Hirschberg R (1996). Growth hormone, the insulin-like growth factor system, and the kidney. Endocrinol. Rev. 17: 423-480.
10. Harris AG (1996). Clinical features of acromegaly. In: Acromegaly and Its Management, AF Daly (ed). Lippincott-Raven Publishers, New York, pp. 24-37.
11. Harris WH, Heaney RP, Jowsey J, Cockin J, Akin SC, Graham J, and Weinberg EH (1972). Gross hormone: The effect of skeletal renewal in the adult dog. I. Morphometric studies. Calcif. Tiss. Res. 10: 1-13.
12. Heaney RP, Harris WH, Cockin J, and Weinberg EH (1972). Growth hormone: The effect on skeletal renewal in the adult dog. II. Mineral kinetic studies. Calcif. Tiss. Res. 10: 14-22.
13. Hickey G, Jacks T, Schleim K-D, Frazier E, Chen H, Krupa D, Fenney W, Nargund R, Patchett A, and Smith RG (1997). Repeat administration of growth hormone secretagogue MK-0677 increases and maintains elevated IGF-1 levels in beagles. J. Endocrinol. 152: 183-192.
14. Jacks T, Smith R, Judith F, Schleim K-D, Frazier E, Chen H, Krupa D, Hora D Jr, Nargund R, Patchett A, and Hickey G (1996). MK-0677, a potent, novel, orally-active growth hormone (GH) secretagogue: GH, IGF-1 and other hormonal responses in beagles. Endocrinology 137: 5284-5289.
15. Jorgensen JOL, Moller J, Skakkebak NE, Weeke J, and Christiansen JS (1992). Thyroid function during growth hormone therapy. Horm. Res. 38 (suppl.): 63-67.
16. Laroque P, Molon-Noblot S, Prahalada S, Stabinski LG, Hoe C-M, Peter CP, Duprat P, and van Zwieten MJ (1998). Morphological changes in the pituitary gland of dogs chronically exposed to exogenous growth hormone. Toxicol. Pathol. 26: 201-206.
17. Leung FC, Jones B, Steelman SL, Rosenblum CL, and Kopchick JJ (1986). Purification and physiochemical properties of a recombinant bovine growth hormone produced by cultured murine fibroblasts. Endocrinology 119: 1489-1496.
18. Levene H (1960). In: Contributions to Probability and Statistics, Stanford University Press, Stanford, California, p. 278.
19. Moalli MR, Dysko RC, Rush GH, Chrisp CE, Decoster JL, Sweet KA, and Goldstein SA (1996). Oxytetracycline-induced nephrotoxicosis in dogs after intravenous administration for experimental bone labeling. Lab Anim. Sci. 46: 497-502.
20. Molon-Noblot S, Laroque P, Prahalada S, Stabinski LG, Hoe C-M, Peter CP, Duprat P, and van Zwieten MJ (1998). Effect of chronic growth hormone administration on skeletal muscle in dogs. Toxicol. Pathol. 26: 207-212.
21. Pratt JH, Peacock M, and Henry DP (1993). Effect of recombinant human growth hormone on adreno-cortical function, and on sodium and potassium homeostasis. Pharmacology 47: 36-42.
22. Shapiro SS and Wilk MB (1965). An analysis of variance test for normality (complete samples). Biometrika 52: 591-611.
23. Sloan JM and Oliver IM (1975). Progestagen-induced diabetes in the dog. Diabetes 24: 337-344.
24. Smith RG, Chang K, Pong S-S, Leonard R, Cohen CJ, Arena JP, Hickey GJ, Chang CH, Jacks T, Drisko J, Robinson ICAF, Dickson SL, and Leng G (1996). Mechanism of action of GHRP-6 and nonpeptidyl growth hormone secretagogues. In: Growth Hormone Secretagogues, BB Bercu and RF Walker (eds). Springer-Verlag, New York, pp. 147-163.
25. Snedecor G and Cochran W (1980). Statistical Methods, 7th ed. Iowa State University Press, Ames, Iowa, pp. 276-279.
26. Tucker MJ (1971). Some effects of prolonged administration of a progestagen to dogs. In: The Correlation of Adverse Effects in Man with Observations in Animals, SB De and C Baker (eds). Excerpta Medica, Amsterdam, pp. 228-238.
27. Tukey JW, Ciminera JL, and Heyse JF (1985). Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 41: 295-301.